Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population

Anticancer Research

Volumn 28, Issue 5 A, 2008, Pages 2807-2811

  Kwak, Sun Young ^a   Kim, Un Kyung ^b   Cho, Hyo Jin ^a   Lee, Hee Keun ^b   Kim, Hye Jin ^a   Kim, Nam Keun ^a   Hwang, Seong Gyu ^a  

^a CHA University   (South Korea)

^b Kyungpook National University   (South Korea)

Author keywords

HCC; MTHFR; MTRR; Polymorphism; Risk factors

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); METHIONINE SYNTHASE REDUCTASE;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC ASSOCIATION; HEPATITIS B; HUMAN; KOREA; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FERREDOXIN-NADP REDUCTASE; GENE FREQUENCY; GENOTYPE; HUMANS; LIVER NEOPLASMS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 55749087866     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Annual Report for the Cause of Mortality in 2005, Korea National Statistical Office. Seoul, 2006.
2. Parkin DM: Global cancer statistics in the year 2000. Lancet Oncol 2: 533-543, 2001.
3. Duthie SJ: Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull 55: 578-592, 1999.
4. Wei Q, Shen H, Wang LE, Duphorne, CM, Pillow PC, Guo Z, Qiao Y and Spitz MR: Association between low dietary folate intake and suboptimal cellular DNA repair capacity. Cancer Epidemiol Biomarkers Prev 12: 963-969, 2003.
5. Bailey LB and Gregory JF III: Polymorphisms of methylene-tetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J Nutr 129: 919-922, 1999.
6. Frosst P, Blom HJ, Milos R, Goyette, P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuve LP and Rozen R: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10: 111-113, 1995.
7. van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP and Blom HJ: A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62: 1044-1051, 1998.
8. Chango A, Boisson F, Barbe F, Quilliot D, Droesch S, Pfister M, Fillon-Emery N, Lambert D, Frémont S, Rosenblatt DS and Nicolas JP: The effect of 677C>T and 1298A>C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects. Br J Nutr 83: 593-596, 2000.
9. Weisberg I, Tran P, Christensen B, Sibani S and Rozen R: A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metabol 64: 169-172, 1998.
10. Matsuo K, Suzuki R, Hamajima N, Ogura M, Kagami Y, Taji H, Kondoh E, Maeda S, Asakura S, Kaba S, Nakamura S, Seto M, Morishima Y and Tajima K: Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood 97: 3205-3209, 2001.
11. Ko KH, Kim NK, Yim DJ, Hong SP, Park PW, Rim KS, Kim S and Hwang SG: Polymorphisms of 5,10-methylenetetrahydrofolate reductase (MTHFR C677T) and thymidylate synthase enhancer region (TSER) as a risk factor of cholangiocarcinoma in a Korean population. Anticancer Res 26: 4229-4233, 2006.
12. Gaughan DJ, Kluijtmans LA, Barbaux S, McMaster D, Young IS, Yarnell JWG, Evans A and Whitehead AS: The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 157: 451-456, 2001.
13. Matsuo K, Hamajima N, Hirai T, Kato T, Inoue M, Takezaki T and Tajima K: Methionine synthase reductase gene A66G polymorphism is associated with risk of colorectal cancer. Asian Pac J Cancer Prev 3: 353-359, 2002.
14. Slattery ML, Potter JD, Samowitz W, Schaffer D and Leppert M: Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 8: 513-518, 1999.
15. Skibola CF, Smith MT, Kane E, Roman E, Rollinson S, Cartwright RA and Morgan G: Polymorphisms in the melhylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 96: 12810-12815, 1999.
16. Keku T, Millikan R, Worley K, Winkels S, Eaton A, Biscocho L, Martin C and Sandler R: 5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African-Americans and whites. Cancer Epidemiol Biomarkers Prev 11: 1611-1621, 2002.
17. Mu LN, Cao W, Zhang ZF, Cai L, Jiang QW, You NC, Goldstein BY, Wei GR, Chen CW, Lu QY, Zhou XF, Ding BG, Chang J and Yu SZ: Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary hepatocellular carcinoma (HCC) in a Chinese population. Cancer Cause Control 18: 665-675, 2007.
18. Yuan JM, Lu SC, Van Den Berg D, Govindarajan S, Zhang ZQ, Mato JM and Yu MC: Genetic polymorphism in the methylenetetrahydrofolate reductase and thymidylate synthase genes and risk of hepatocellular carcinoma. Hepatology 46: 749-758, 2007.
19. Lahiri DK and Nurnberger JI Jr: A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19: 5444, 1991.
20. Laraqui A, Allami A, Carrie A, Raisonnier A, Coiffard AS, Benkouka F, Bendriss A, Benjouad A, Bennouar N, El Kadiri N, Benomar A, Fellat S and Benomar M: Relation between plasma homocysteine, gene polymorphisms of homocysteine metabolism-related enzymes, and angiographically proven coronary artery disease. Eur J Intern Med 18: 474-483, 2007.
21. Skibola CF, Forrest MS, Coppede F, Agana L, Hubbard A, Smith MT, Bracci PM and Holly EA: Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood 104: 2155-2162, 2004.
22. Stolzenberg-Solomon RZ, Qiao YL, Abnet CC, Abnet CC, Ratnasinghe DL, Dawsey SM, Dong ZW, Taylor PR and Mark SD: Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev 12: 1222-1226, 2003.
23. Brilakis ES, Berger PB, Ballman KV and Rozen R: Methylenetetrahydrofolate reductase (MTHFR) 677C>T and methionine synthase reductase (MTRR) 66A>G polymorphisms: association with serum homocysteine and angiographic coronary artery disease in the era of flour products fortified with folic acid. Atheroscler 168: 315-322, 2003.
24. Jacques PF, Bostom AG, Selhub J, Rich S, Ellison C, Eckfeldt JH, Gravel RA and Rozen R: Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study. Atheroscler 166: 49-55, 2003.
25. Kluijtmans LA, Young IS, Boreham CA, Murray L, McMaster D, McNulty H, Strain JJ, McPartlin J, Scott JM and Whitehead AS: Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults. Blood 101: 2483-2488, 2003.
26. Vaughn JD, Bailey LB, Shelnutt KP, Dunwoody KM, Maneval DR, Davis SR, Quinlivan EP, Gregory JF III, Theriaque DW and Kauwell GP: Methionine synthase reductase 66A>G polymorphism is associated with increased plasma homocysteine concentration when combined with the homozygous methylenetetrahydrofolate reductase 677>T variant. J Nutr 134: 2985-2990, 2004.
27. Chen J, Giovannucci E, Kelsey K, Rimm EB, Stampfer MJ, Colditz GA, Spiegelman D, Willett WC and Hunter DJ: A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 56: 4862-4864, 1996.
28. Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, Willett WC, Selhub J, Hennekens CH and Rozen R: Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 57: 1098-1102, 1997.
29. Franco RF, Simoes BP, Tone LG, Gabellini SM, Zago MA and Falcao RP: The methylenetetrahydrofolate reductase C677T gene polymorphism decreases the risk of childhood acute lymphocytic leukaemia. Br J Haematol 115: 616-618, 2001.
30. Kim NK, Chong SY, Jang MJ, Hong SH, Kim HS, Cho EK, Lee JA, Ahn MJ, Kim CS and Oh D: Association of the methylenetetrahydrofolate reductase polymorphism in Korean patients with childhood acute lymphoblastic leukemia. Anticancer Res 26: 2879-2881, 2006.
31. Oh D, Kim NK, Jang MJ, Kim HC, Lee JH, Lee JA, Ahn MJ, Kim CS, Kim HS, Park S, Cho HS and Min YH: Association of the 5,10-methylenetetrahydrofolate reductase (MTHFR C677T and A1298C) polymorphisms in Korean patients with adult acute lymphoblstic leukemia. Anticancer Res 27: 3419-3424, 2007.
32. Song C, Xing D, Tan W, Wei Q and Lin D: Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 61: 3272-3275, 2001.
33. Shen H, Spitz MR, Wang LE, Hong WK and Wei Q: Polymorphisms of methylenetetrahydrofolate reductase and risk of lung cancer: a case-control study. Cancer Epidemiol Biomarkers Prev 10: 397-401, 2001.
34. Kim JK, Kim S, Han JH, Chong SY, Hong SP, Hwang SG, Ahn JY, Cha KY, Oh D and Kim NK: Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of stomach cancer in a Korean population. Anticancer Res 25: 2249-2252, 2005.
35. Gershoni-Baruch R, Dagan E, Israeli D, Kasinetz L, Kadouri E and Friedman E: Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer in Jewish women. Eur J Cancer 36: 2313-2316, 2000.
36. Goodman MT, McDuffie K, Hernandez B, Wilkens LR, Bertram CC, Killeen J, Le Marchand L, Selhub J, Murphy S and Donlon TA: Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia. Cancer Epidemiol Biomarkers Prev 10: 1275-1280, 2001.
37. Lin J, Spitz MR, Wang Y, Schabath MB, Gorlov IP, Hernandez LM, Pillow PC, Grossman HB and Wu X: Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study. Carcinogenesis 25: 1639-1647, 2004.
38. Siemianowicz K, Gminski J, Garczorz W, Slabiak N, Goss M, Machalski M and Magiera-Molendoska H: Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms in patients with small cell and non-small cell lung cancer. Oncol Rep 10: 1341-1344, 2003.
39. Saffroy R, Pham P, Chiappini F, Gross-Goupil M, Castera L, Azoulay D, Barrier A, Samuel D, Debuire B and Lemoine A: The MTHFR 677C>T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis. Carcinogenesis 25: 1443-1448, 2004.